Cargando…
UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
Autores principales: | Bastian, Lorenz, Hartmann, Alina M., Beder, Thomas, Hänzelmann, Sonja, Kässens, Jan, Bultmann, Miriam, Hoeppner, Marc P., Franzenburg, Sören, Wittig, Michael, Franke, Andre, Nagel, Inga, Spielmann, Malte, Reimer, Niklas, Busch, Hauke, Schwartz, Stefan, Steffen, Björn, Viardot, Andreas, Döhner, Konstanze, Kondakci, Mustafa, Wulf, Gerald, Wendelin, Knut, Renzelmann, Andrea, Kiani, Alexander, Trautmann, Heiko, Neumann, Martin, Gökbuget, Nicola, Brüggemann, Monika, Baldus, Claudia D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162919/ https://www.ncbi.nlm.nih.gov/pubmed/35397658 http://dx.doi.org/10.1038/s41375-022-01557-6 |
Ejemplares similares
-
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL
por: Passet, Marie, et al.
Publicado: (2022) -
Ribosomal DNA promoter recognition is determined in vivo by cooperation between UBTF1 and SL1 and is compromised in the UBTF-E210K neuroregression syndrome
por: Tremblay, Michel G., et al.
Publicado: (2022) -
Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods
por: Kotrová, Michaela, et al.
Publicado: (2022) -
Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia
por: Harrop, Sean, et al.
Publicado: (2023) -
Analysis of (CAG)(n) expansion in ATXN1, ATXN2 and ATXN3 in Chinese patients with multiple system atrophy
por: Zhou, X., et al.
Publicado: (2018)